Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
Two major pharmaceutical companies have announced new and much lower prices for antiretrovirals for African and some other poor countries, along with a uniform pricing policy which should simplify negotiations for access to the drugs.
James
J S
JS
D019380:Anti-HIV Agents / Q000191:economics* / Q000600:supply & distribution; D003906:Developing Countries; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D015658:HIV Infections / Q000188:drug therapy; D006297:Health Services Accessibility; D006801:Humans
D019380:Anti-HIV Agents